News & Updates
Filter by Specialty:
Age does not affect palbociclib dose reduction, discontinuation in breast cancer patients
The age of patients with advanced breast cancer appears to have no influence on the rate of palbociclib dose reductions or discontinuations secondary to neutropaenia, a study has shown.
Age does not affect palbociclib dose reduction, discontinuation in breast cancer patients
06 Jan 2023Investigational antisense oligonucleotide for chronic HBV infection shows positive results
Treatment with the antisense oligonucleotide bepirovirsen appears to lead to sustained loss of hepatitis B surface antigen (HBsAg) and hepatitis B virus (HBV) DNA in up to 10 percent of patients with chronic HBV infection, according to the results of the phase IIb study B-Clear.
Investigational antisense oligonucleotide for chronic HBV infection shows positive results
06 Jan 2023Noninvasive retinal photography–based AI model accurate and sensitive for Alzheimer’s disease screening
An international team led by researchers from the Chinese University of Hong Kong (CUHK) has successfully developed world’s first artificial intelligence (AI) model that can detect Alzheimer’s disease (AD) solely through retinal photographs.
Noninvasive retinal photography–based AI model accurate and sensitive for Alzheimer’s disease screening
06 Jan 2023Tai Chi associated with decreased migraine frequency in Hong Kong Chinese women
A randomized controlled trial (RCT) shows that 1 hour of Tai Chi training per day, 5 days a week, significantly decreases the frequency of migraine attacks among Hong Kong Chinese women with episodic migraine.
Tai Chi associated with decreased migraine frequency in Hong Kong Chinese women
06 Jan 2023Can breast cancer survivors temporarily stop endocrine therapy to attempt pregnancy?
Young breast cancer survivors could safely temporarily stop adjuvant endocrine therapy (ET) to attempt pregnancy, according to primary results of the POSITIVE* trial presented at SABCS 2022.
Can breast cancer survivors temporarily stop endocrine therapy to attempt pregnancy?
05 Jan 20235α-reductase inhibitor treatment implicated in dementia
Men who are receiving treatment with 5α-reductase inhibitors (5-ARIs) are at increased risk of dementia in the immediate period after initiating treatment, a study has shown. Of note, both finasteride and dutasteride are associated with depression, but neither of them is linked to suicide.
5α-reductase inhibitor treatment implicated in dementia
05 Jan 2023Postoperative neutropaenia tied to early CRBSI in children with leukaemia
Paediatric patients with acute myeloid leukaemia and other leukaemias (AML/OLs), especially those with persistent neutropaenia during the first 30 postoperative days, are at increased risk of early catheter-related bloodstream infections (CRBSIs), according to a Singapore study.